Suchergebnisse - "Wachsmuth, Luke"

PubPharm (3)

1

NUTMEG : A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma

enthalten in: Neuro-oncology advances | 2023

von Sim, H. | Wachsmuth, L. | Barnes, E. | +26

2

Non-inferiority of fragmented care for high-risk pediatric neuroblastoma patients : a single institution analysis

enthalten in: Pediatric hematology and oncology | 2021

von Tarnasky, A. | Achey, M. | Wachsmuth, L. | +6

3

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy

enthalten in: The Journal of clinical investigation | 2020

von Theivanthiran, B. | Evans, K. | DeVito, N. | +12

1
[1]